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Abstract
Context
An estimated 21% of non-U.S.-born persons in the United States have a reactive tuberculin
skin test (TST) and are at risk of progressing to TB disease. The effectiveness of strategies
by healthcare facilities to improve targeted TB infection testing and linkage to care among
this population is unclear.
Evidence acquisition
Following Cochrane guidelines, we searched several sources to identify studies that
assessed strategies directed at healthcare providers and/or non-U.S.–born patients in U.S.
healthcare facilities.
Evidence synthesis
Seven studies were eligible. In a randomized controlled trial (RCT), patients with reactive
TST who received reminders for follow-up appointments were more likely to attend appoint-
ments (risk ratio, RR = 1.05, 95% confidence interval 1.00–1.10), but rates of return in a
quasi-RCT study using patient reminders did not significantly differ between study arms (P =
0.520). Patient-provider language concordance in a retrospective cohort study did not
increase provider referrals for testing (P = 0.121) or patient testing uptake (P = 0.159). Of
three studies evaluating pre and post multifaceted interventions, two increased TB infection
testing (from 0% to 77%, p < .001 and RR 2.28, 1.08–4.80) and one increased provider
referrals for TST (RR 24.6, 3.5–174). In another pre-post study, electronic reminders to pro-
viders increased reading of TSTs (RR 2.84, 1.53–5.25), but only to 25%. All seven studies
were at high risk of bias.
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Conclusions
Multifaceted strategies targeting providers may improve targeted TB infection testing in non-
U.S.-born populations visiting U.S. healthcare facilities; uncertainties exist due to low-quality
evidence. Additional high-quality studies on this topic are needed.
Background
Mycobacterium tuberculosis disease (TB) remains a serious global health problem. In 2017,
there were an estimated 10.0 million new cases globally and 1.6 million TB-related deaths, of
which 1.3 million were among persons without HIV and 300,000 were among persons living
with HIV.[1] In the United States (U.S.), TB incidence declined significantly over the past two
decades, from 6.6 per 100,000 persons in 1998 to 2.8 in 2017.[2] Despite this progress, TB
remains a public health concern in the United States, where 70% of reported TB cases in 2017
were among non-U.S.-born persons.[2] Untreated latent tuberculosis infection (LTBI) confers
an estimated risk of reactivation to TB disease of .098 per 100 person years among non-U.S.-
born persons.[3] According to the 2011–2012 U.S. National Health and Nutrition Examina-
tion Survey (NHANES), a nationally representative survey, reactivity to the tuberculin skin
test (TST) for TB infection, an indicator of LTBI prevalence, was estimated at 5% across all
populations and 21% in non-U.S.-born persons.[4] A recent study looking at genotyped TB
cases in the U.S. from 2011 to 2014 estimated that 14% of TB cases resulted from recent trans-
mission.[5] Among non-U.S.-born persons only 8% of cases were estimated to result from
recent transmission (compared to 27% among U.S. born persons), suggesting that, if one
assumes that cases not attributed to recent transmission are due to reactivation of LTBI, 93%
of genotyped cases among non-U.S born persons were due to reactivation of LTBI (compared
to 73% among U.S. born persons).[5] Thus, non-U.S.-born persons have a higher prevalence
of LTBI reactivation relative to US born persons.[5] Fortunately, LTBI reactivation to TB can
be prevented through LTBI treatment.
Medical evaluation and treatment for TB disease before entering the U.S. is required for
persons seeking permanent U.S. residence (i.e., immigrants and refugees), but not for other
visa categories (e.g., students, skilled workers and tourists).[6] The medical evaluation includes
review of medical history; physical examination; interferon gamma release assay (IGRA) when
indicated; chest radiograph when indicated; and sputum smears and culture testing for Myco-
bacterium tuberculosis. As of 2018, TB infection testing using IGRA is also required for visa
applicants aged 2–14 years (but not for other ages) from countries with annual TB incidence
of�20 per 100,000 population. Prior to that, from 2009–2017, TST or IGRA was acceptable,
and currently TST could be used if IGRA is not licensed in the country.[6] LTBI is diagnosed
if an asymptomatic patient has a positive TST or IGRA; a chest radiograph not suggestive of
TB; and no known HIV infection. Self-reported HIV-positive patients should undergo addi-
tional testing to rule out TB disease.
CDC and the U.S. Preventive Services Task Force recommend that U.S. healthcare provid-
ers offer targeted testing and treatment (TTT) for LTBI to non-U.S.-born persons and other
populations at increased risk of LTBI.[7–9] Yet many non-U.S.-born persons are still unaware
of their LTBI since providers fail to test them.[10–12] Our recently published systematic
review [13] examined community-based strategies for TTT of non-U.S.-born persons. How-
ever, since many non-U.S.-born persons, especially those with legal status, are integrated into
mainstream medical care, this study identifies effective strategies to improve TB infection test-
ing and linkage to care in non-U.S.-born populations in healthcare settings.
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Objective
To evaluate the effectiveness of healthcare facility-based strategies to improve targeted TB
infection testing and linkage to care among non-U.S.-born populations in the U.S. from pub-
lished studies.
Methods
We conducted a systematic review following Cochrane Handbook[14] guidance in developing
and conducting searches, selecting studies for inclusion, extracting data and assessing risk of
bias. We followed reporting guidance in the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA).[15] We registered our review protocol in the PROSPERO
online registry (registration number CRD42016038476).
Eligible study designs included randomized controlled trials (RCT), quasi-RCTs (RCTs
lacking proper randomization), and non-randomized controlled trials with parallel or histori-
cal (pre-post) comparator or control conditions. We excluded descriptive studies lacking base-
line data; studies of diagnostic test accuracy; and non-U.S. studies. Eligible strategies addressed
at least one outcome from the testing portion of the LTBI TTT cascade in non-U.S.-born
asymptomatic patients, and were aimed at healthcare providers, non-U.S.-born patients, or
both. Eligible provider populations were physicians, nurse practitioners, registered nurses,
physician assistants and other clinically trained personnel. Eligible healthcare facilities
included primary care outpatient clinics, specialty referral clinics, office-based medical prac-
tices, hospitals (including emergency departments) and community-based health centers.
We included studies that explicitly reported that at least some of their participants were
born outside of the U.S, regardless of their age of arrival. We excluded studies in “refugee”
populations, as these patients are required to undergo pre-departure evaluation for TB before
leaving their home countries and are evaluated again once in the U.S.[16] We also excluded
studies in which offering and receiving TB infection tests was mandatory (e.g. testing in pri-
sons or required employee testing). Additionally, we excluded studies where TST or IGRA
testing was used primarily as part of a diagnostic workup in persons with symptoms consistent
with active TB disease. Studies in which TB medical risk factors alone (e.g. diabetes, HIV,
rheumatoid arthritis) triggered provider offers of TB infection testing were also excluded
because being a non-U.S.-born person is a hard-to-ascertain demographic risk factor in
healthcare settings while those with medical conditions can easily be identified and targeted
for LTBI screening. Studies where mass testing was offered were excluded as well, unless test-
ing based on non-U.S.-born status was done with results reported separately for non-U.S.-
born individuals.
To be included, studies needed a comparator (baseline data for single arm studies or a par-
allel arm with a control condition) and had to report at least one step in the testing cascade: 1)
proportion of eligible non-U.S.-born patients screened or identified for TB infection testing; 2)
proportion of providers offering TB infection testing to non-U.S.-born patients; 3) proportion
of non-U.S.-born patients receiving TB infection testing; or 4) proportion of non-U.S.-born
patients receiving TB infection testing results. The unit of analysis could be the individual
patient, individual provider or the healthcare facility. Finally, we included published, “in
press,” and unpublished (grey) studies in any language.
Searches, screening and data collection
We developed a comprehensive search strategy and searched the Cochrane Central Register of
Controlled Trials, EMBASE, PubMed and Web of Science. Our search strategy included Medi-
cal Subject Heading (MeSH) terms and keywords relevant to TB. The search period ranged
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from the earliest records to the search date (28 March 2016). We ran updated searches on
December 17, 2018, to capture new research published while this manuscript was in develop-
ment. See “S1 Appendix” for our original and updated database search strategies.
We also searched all available abstracts from the American Public Health Association
(APHA) (2000–2018) and the International Union Against TB and Lung Disease North Amer-
ica Region (2014–2018) conferences. Selected “grey literature” (e.g. doctoral dissertations
indexed in ProQuest, CINAHL, and WorldCat databases, all issues of TB Notes,[17] govern-
ment reports and other potentially relevant research) was also searched. As with our main
database search, we reviewed grey literature in 2016 and then reviewed newly published mate-
rial in 2018. We also searched for ongoing studies indexed in the clinical trials registry at the
U.S. National Institutes of Health and emailed TB experts to see if they knew of ongoing or
completed research that we might have missed.[18] We also searched the bibliographies of
included studies as well as the articles that cited them for additional eligible studies.
We imported search results into bibliographic citation management software[19] and
excluded duplicate references.[19] Two of three reviewers (AM, HH or JB) independently
examined titles and abstracts to identify potentially eligible reports and then independently
assessed each full text article and applied inclusion criteria to determine study eligibility. We
resolved any differences of opinion through discussion.
Two authors (AM, JB) independently extracted data from each study, entered these data
into standardized, piloted data collection forms and compared extracted data. Data collection
forms captured details of study populations, intervention characteristics, study design, results
for specific outcomes of interest and details necessary to assess risk of bias. We contacted cor-
responding authors of included studies for additional data when needed.
Critical appraisal
We used the Cochrane Collaboration tool for assessing risk of bias in included studies.[14]
This instrument assesses bias risk in terms of sequence generation, allocation concealment,
blinding, incomplete outcome data, selective outcome reporting and other potential biases.
With non-randomized studies, we additionally considered socio-demographic comparability
of study groups at baseline, potential for measurement bias, adequacy of measures to control
for confounding and adequacy of time for intervention follow-up.
Data analysis and synthesis
We used Stata to calculate cascade step proportions, risk ratios (RR) and their 95% confidence
intervals (CI) to measure effectiveness, as well as p-values for differences with comparator
arms. [20] We did not conduct meta-analysis to pool data since identified data were too heter-
ogenous and not comparable.
Evidence quality
We used the Grading of Recommendations, Assessment, Development and Evaluations
(GRADE) methodology to assess the quality of evidence for each pre-specified outcome across
the literature.[21] In GRADE, “quality of evidence” is defined as “the extent of our confidence
that the estimates of effect are correct."[14] The quality rating across studies has four levels:
high, moderate, low, or very low. Data from RCTs are initially considered to be of high quality
but can be downgraded for five reasons: 1) risk of bias; 2) indirectness of evidence; 3) unex-
plained heterogeneity or inconsistency of results; 4) imprecision of results; or 5) high probabil-
ity of publication bias. Data from non-randomized controlled trials are considered to be of low
quality but can be upgraded for three reasons: 1) large magnitude of effect; 2) improved
Healthcare facility-based strategies to improve TB testing in non-U.S.-born population
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outcomes despite plausible confounders that would be expected to worsen outcomes; or 3) the
presence of a dose-response gradient.
Results
The original and updated searches yielded a total of 3,652 unique records. Based on eligibility
criteria, we excluded 3,582 records through examining titles, abstracts and indexing terms. We
obtained 70 articles for full-text review, and ultimately excluded 63 of those articles (justifica-
tions for exclusion indexed in “S2 Appendix”). We included seven studies concerned with tar-
geted TB testing in non-U.S.-born populations in the U.S., including two exclusively non-U.
S.-born studies [22, 23] and five studies [24–28] with some U.S. born participants. See Fig 1 for
a PRISMA flow-chart of our screening process and “S1 Prisma Checklist” for the Prisma
Checklist.
Descriptive summary and results from included studies
Studies targeting healthcare providers and clinic personnel. Steele and colleagues
(2005) reported a pre-post study they conducted from 2002–2003 in two community health
clinics in Denver, Colorado.[24] Investigators aimed to assess provider compliance to CDC
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection guidelines
through implementation of a computerized clinical decision support system (CDSS).[8] The
CDSS was designed to trigger printed alerts for placement in patients’ records when their
Fig 1. Identification and screening of citations: Systematic review of healthcare facility-based strategies to
improve targeted testing for latent tuberculosis infection in non-U.S.-born populations in the United States.
https://doi.org/10.1371/journal.pone.0223077.g001
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personal information indicated that they were at high risk of LTBI according to the CDC
guidelines. There was also a web-based data entry component to walk the healthcare providers
through the TB infection testing process once an alert was triggered. Additional intervention
components are described in Table 1. Investigators reviewed a random sample of 249 non-U.
S.-born patient charts (97% born in Mexico) to assess provider compliance with the CDC
guidelines measured by the proportion of eligible patients returning for TST interpretation. Of
the 249 patient charts examined, investigators assessed provider compliance with 146 (59%)
patients in the pre-CDSS period, and 103 (41%) patients after (see Fig 2). Following CDSS
implementation, provider compliance improved from 9% (13/146) to 25% (26/103), (RR 2.84,
CI 1.53 to 5.25; p<0.001), leaving 75% as non-compliant.
From 2009–2010, Kempker and colleagues (2012)[22] implemented a multifaceted perfor-
mance improvement intervention in Atlanta, Georgia, targeting healthcare providers and
other clinic personnel.[22] The goal of the intervention was to improve identification of those
at increased risk of TB infection (active TB disease or latent TB infection) and subsequent
referral for TB infection testing. The evaluation compared pre- to post-intervention propor-
tions. Following CDC guidelines, investigators developed a questionnaire to identify non-U.
S.-born patients at increased risk of TB infection, which was administered by a nursing assis-
tant during patient intake and placed in the patient’s medical records for review by the health-
care provider during the appointment. When appropriate, providers referred patients for a
TST based on the questionnaire. The study sample was entirely non-U.S.-born; fifty five per-
cent of patients in the post intervention condition were from Mexico; country of origin of
patients before the intervention was not reported. Of 71 non-U.S.-born patient charts reviewed
before the intervention, one patient was excluded from analysis because he already received a
diagnostic TB test and one patient (1%) was referred for TB infection testing by the provider
but did not receive a TST. In the seven months following the start of the intervention, out of
the 165 non-U.S.-born patients who met TB risk criteria, 58 (35%) were referred by their pro-
vider to receive a TST. Thirty-six (62%) of those referred followed through and received a
TST, two of whom were ultimately diagnosed with TB. The intervention improved referral for
TST (RR 24.6, CI 3.5 to 174.1; p = 0.001). Statistical assessment of change in receiving TST was
not meaningful due to lack of cases at baseline.
Schultz and colleagues (2018) conducted a pre-post study at the Denver Hospital Internal
Medicine and Pediatrics (Med-Peds) resident clinic from October 2016 through June 2017.
[25] The clinic is located in Southwest Denver and primarily serves low-income Hispanic
patients, including adults and children. The intervention was a multifaceted quality improve-
ment project targeting clinic providers and staff, consisting of one education session on LTBI;
an email reminder to clinic providers about screening for LTBI; and an LTBI screening flow-
chart posted in the resident area of the clinic. The purpose of the intervention was to improve
(i) identification of non-U.S.-born persons at risk of LTBI and (ii) TB infection testing of those
at risk of TB using QuantiFERON1-TB (QFT). Limited demographics on study participants
were reported. The analytic sample (n = 172) included participants who met CDC guidelines
for being at risk of LTBI.[29] Reported results were not stratified by age group. The mean age
of patients in the pre-intervention group (n = 76) was 44 years (range 2–77) and 62% were
female. In the post-intervention group (n = 96), the mean age of patients was 46 years and 59%
were female. Outcomes reported included the proportion of individuals identified as being
at risk of LTBI who received a QFT, and the proportion who tested positive and received a
chest x-ray. Criteria for identifying who was “at risk of LTBI” were not described in the paper.
Only one outcome (the proportion who received a QFT) was reported for both pre- and post-
intervention conditions. During the pre-intervention phase (October-November 2016), 11%
(8/76) of patients who had at least one LTBI risk factor were screened for LTBI via QFT
Healthcare facility-based strategies to improve TB testing in non-U.S.-born population
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Table 1. Characteristics of healthcare facility-based targeted TB testing studies non-U.S.-born populations in the US.
Author/
Year/Publication
type
Design Setting Intervention & comparator Outcome and characteristics
Studies targeting providers and other clinic personnel
Steele 2005 Peer
Reviewed
Article
Pre-post Colorado,
2002–2003
Electronic health record prompts vs. no prompts In
the intervention phase, when providers encountered
patients <40 years of age, who were born in a high-
risk TB country, they received on-screen prompts for
TB screening in the patients’ electronic health records
(EHR), followed by guided web-based documentation.
Clinic personnel also received computer-generated
paper alerts.
Outcome analyzed: “completed LTBI screening”
which entailed the use of a computerized clinic
decision support system that alerted providers when a
patient was at high risk of LTBI, the provider offering
a TB infection test and then placing the test in
consenting patients. Analysis sample: n = 8463.
Demographics: Investigators do not report the
number of providers evaluated. No provider
demographic details reported. All patients were non-
U.S.-born; 97% were born in Mexico.
Kempker 2012
Peer Reviewed
Article
Pre-post Georgia, 2009–
2010
Multifaceted organizational improvement vs.
previous organization and practice standard The
intervention involved a nurse administered
questionnaire placed in patient files for physicians to
review and, if appropriate offer TB infection testing.
Other components: training of clinic personnel and
coordination with relevant county health departments.
Outcome analyzed: referred for TB infection test and
received TB infection test. Analysis sample:
asymptomatic patients, n = 165. Demographics: The
entire sample was non-U.S.- born: 58% were from
Mexico; 7% were from Colombia; and 35% came from
other countries. Mean age: 46 ± 14 yrs (range 20–85
yrs). 70% female. Mean time in U.S.: 11 ± 6.8 yrs.
Mean household size: 4 ± 2.0.
Schultz 2018
Conference
Abstract
Pre-post Colorado,
2016–2017
Multifaceted education, reminder and posted
screening guidelines vs. no education session,
reminder or posted guidelines. In the intervention
phase, medicine-pediatrics (Med-Ped) residents and
staff at Denver Hospital attended an education session
and received an email reminder to screen for LTBI.
Additionally, a flowchart with screening guidelines
was visibly posted in the resident/staff area of the
clinic.
Outcome analyzed: proportion of individuals who
were administered an TB infection test among those
who were identified as being at high risk of LTBI and
appropriately screened. Analysis sample: clinic
patients meeting LTBI screening guidelines, n = 172.
Demographics: pre-intervention phase: n = 76, mean
age: 44 (range 2–77 yrs). 62% Female. post
intervention phase: n = 96, mean age: 46 (range 2–93
yrs). Female: 59%.
Anand 2018 Peer
Reviewed
Article
Pre-post Florida, 2015–
2017
Multifaceted quality improvement project vs.
previous standard practice. The intervention
included an educational training for providers and
staff in a free student-run clinic as well as the
introduction of an LTBI screening tool (questionnaire)
adapted from CDC LTBI screening guidelines
Outcome analyzed: “screened for LTBI” which
entailed using a screening tool (questionnaire)
adapted from CDC guidelines and, when deemed
appropriate offering a TB infection test and then
placing the test in consenting patients. Analysis
sample: clinic patients, n = 72 (20 before and 52 after
intervention). Demographics (only reported for post/
intervention arm): 5% non-U.S.-born; 30% “emigrated
from endemic region”.
Studies targeting patients
Tanke 1994 Peer
Reviewed
Article
Quasi-RCT California,
1992
Telephone reminder vs. no reminder. In the
intervention arm, patients who had a positive TST
were sent one of four types of reminders the evening
before they were due to attend their next appointment
for a chest x-ray and LTBI treatment evaluation. The
control arm received no reminders. Reminders could
be ‘basic reminders’ or have additional enhancement
(e.g. include an authority endorsement). All patients
were given a copy of the clinic’s schedule and verbally
told which day to return. All reminders “were
recorded by a female speaker, in participants’ home
language, b) identified individuals by name, and c)
gave the time of appointment, clinic address and
phone number of clinic, d) reminded participants to
bring along the record given at time of administration
of test, and e) indicated that the test would have to be
repeated if the reading was not taken the following
day.”
Outcome analyzed: returned for TB infection test
(TST) reading. Analysis sample: Asymptomatic
patients (n = 858). Demographics of entire study
sample: (n = 2008) “home language” of participants:
39% Spanish; 28% Vietnamese; 6% Tagalog; 14%
English; and 14% spoke one of "two other languages".
Median age 19 (range 0–81 yrs). 46% female.
(Continued)
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administration. During the post-intervention phase (May-June 2017), 24% (23/96) of patients
received a QFT. Patients in the intervention arm were more than twice as likely to be screened,
a statistically significant difference (RR = 2.28, CI 1.08 to 4.80; p = 0.023).
Anand and colleagues (2018) conducted a pre-post study from December 2015 to February
2017 at The Keeping Neighbors In Good Health Through Service (KNIGHTS), which provides
free care to underserved populations in Orange County, Florida.[26] The pre-post study was a
multifaceted quality improvement project aimed at improving provider and staff compliance
to CDC LTBI screening guidelines.[29] The intervention consisted of educational training ses-
sions for providers and clinic staff as well as the development of an LTBI screening tool (ques-
tionnaire) for clinic use, which was adapted from CDC LTBI screening guidelines. The
questionnaire was administered by providers three months after the training, and responses
Table 1. (Continued)
Author/
Year/Publication
type
Design Setting Intervention & comparator Outcome and characteristics
Tanke 1997 Peer
Reviewed Article
RCT California, year
not reported
Telephone reminder vs. no reminder. Patients in the
intervention arm received a telephone reminder to
return to the clinic to have their TST read and a
warning that if they did not return in the designated
time frame, they would need to have a new test placed.
Reminders were of one message type, not described in
the report but likely to be of the “basic” message type.
Outcome analyzed: returned for TB infection test
(TST) reading. Analytic Sample: Asymptomatic
adults and children (n = 701). Demographics: “Home
language”: Spanish 29%; Vietnamese 3%; English 68%.
Age�13: 55%. Age �20: 27%. 55% female.
Leng 2011 Peer
Reviewed
Article
Retrospective
cohort
New York,
2003–2005
Language-concordant patient encounters vs.
language-discordant patient encounters. Patients in
the intervention arm were offered language-
concordant patient encounters (in which providers
and patients spoke the same language, and jointly
decided not to use an interpreter) while those in the
control arm received language-discordant patient
encounters (in which providers and patients did not
speak the same language and used the services of an
interpreter.
Outcome analyzed: referred for TB infection test and
received TB infection test
Analysis sample: n = 191.
Demographics: All participants were non-U.S.-born
patients arriving to the U.S. in past five years. Primary
language: 68% Spanish and 29% Mandarin or
Cantonese. None spoke English as primary language.
Of language concordant encounters, 71% were
Spanish concordant, 16% were Mandarin or
Cantonese concordant and 14% were English
concordant.
https://doi.org/10.1371/journal.pone.0223077.t001
Fig 2. Effect of healthcare facility-based strategies on outcome of targeted latent tuberculosis infection testing
cascade in non-U.S.-born populations: referral for testing, receipt of test, tests results read and linkage to care.
LEGEND: Green = control condition, Blue = intervention condition.
https://doi.org/10.1371/journal.pone.0223077.g002
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were added to patient medical records to identify patients recommended to be offered a TB
infection test. The paper also reported treatment initiation and retention among those with a
positive test. However, the only outcome that was reported pre- and post-intervention was the
proportion of clinic patients who were screened for LTBI via the questionnaire and TB infec-
tion test. No demographics (n = 72) were reported, other than the proportion of the 52 patients
post-intervention with specific LTBI risk factors. In this group, five percent of participants
who were screened were non-U.S.-born. Among those testing positive, 30% came from a TB
endemic region (as determined from screening tool list, which included Latin America, Carib-
bean, Africa, Asia, Eastern Europe, Russia and “other”). Since the paper did not describe the
demographics of participates further, it is unclear if children were eligible for participation in
the study. During the pre-intervention phase, none of the twenty patients were screened for
LTBI. Fourteen months after the intervention, three quarters (77%) of 52 patients were
screened for LTBI. Due to the small sample size (and no patients screened pre-intervention), a
risk ratio for intervention effect was not calculated (p<0.001).
Studies targeting healthcare patients
In a study conducted in Santa Clara, California, Tanke and colleagues (1994) used a quasi-
RCT design to test an automated telephone reminder system for improving patient appoint-
ment attendance for chest radiography after receipt of a positive TB infection test.[28] The
proportion of non-U.S.-born patients in the overall sample (N = 2008) was not reported, but
the primary language spoken by 86% of patients was not English. While the overall sample
included both adults and children, the proportion of children was not reported; the median
age of participants was 19 years. The study was carried out at three different types of clinics
representing different phases in the TB test and treat cascade. We limited our analysis to 857
patients at the “reactor clinic”; these patients were being referred to the “Tuberculosis clinic”
where they were to receive chest radiography and evaluation for LTBI treatment after receiving
a positive TST result. The demographics of patients referred to the TB clinic for radiography
were not reported; demographics for the full sample are reported in Table 1. Over a six-month
period, depending on the day of the week, patients in the intervention arm received one of
four types of reminders: basic reminder; “authority endorsed” reminder (which stated at the
beginning that the message was from a public health nurse at the health department); reminder
plus statement of importance (highlighting that appointment attendance was important
because it could prevent the patient and their family from becoming seriously ill); and author-
ity endorsed reminder with statement of importance. The reminders were delivered the even-
ing before their scheduled chest x-ray; the control arm received no reminders. While 57%
(371/651) of patients receiving any reminder attended the TB clinic for their chest radiography
and LTBI treatment evaluation, so did 54% (111/206) of those receiving no message (RR 1.05,
CI 0.91 to 1.21, p = 0.520).
In another study, also in Santa Clara County, Tanke and colleagues (1997) conducted an
RCT using telephone prompts at two of the largest clinics in the county’s immunization pro-
gram.[27] Over a seven-week period, all patients who attended and received a TST were given
an index card, asked to provide their contact info, and told that they might receive a reminder
for a follow-up visit to interpret the TST. Investigators randomly assigned patients to two
arms. Patients or guardians in the intervention arm received phone reminder messages the
evening before they were due to have the TST interpreted, and those in the control arm did
not receive phone messages. This study included adults and children and didn’t stratify results
by age group. Fifty five percent of the sample was 13 years of age or less. The manuscript did
not report number of patients in each arm or the proportion of the sample that was non-U.S.-
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born, but 32% of patients were non-English speakers. We identified denominators of the
respective arms in a Cochrane review.[30] The study showed that 93% (349/376) returned for
TST interpretation in the intervention versus 88% (287/325) in the control arm (RR 1.05, 95%
CI 1.00 to 1.10, p = 0.044).
Leng and colleagues (2011) reported findings from a 2003–2005 study testing the use of lan-
guage interpretation services in a large New York City hospital. In a retrospective cohort
nested in an RCT, investigators offered targeted TB testing to persons recently arrived to the
United States (n = 191) from settings with high TB endemicity.[31] Patients were offered pro-
vider encounters that were either language-concordant (provider and patient spoke the same
language and opted out of using an interpreter) (n = 58; intervention) or language-discordant
(provider and patient spoke different languages, sometimes with the use of an interpreter)
(n = 133; control). The majority (71%) of the language concordant visits were conducted in
Spanish; the rest were Mandarin or Cantonese concordant (15%) or English concordant
(14%). Patients in both arms did not differ significantly in year of U.S arrival or age. In the
concordant arm, 8/58 (14%) were referred for TB infection testing, of whom six (75%) received
a TST. In the discordant arm, 9/133 (7%) of patients were referred for TB infection testing, all
of whom received a TST. The effect sizes were not statistically significant: referrals for TB
infection testing (RR = 2.0, CI 0.83 to 5.02, p = 0.121) and receipt of TST (RR 0.8, CI 0.50 to
1.12, p = 0.159). It is unclear how provider fluency was determined, and it is possible that
some providers may have had “false fluency” (i.e., a provider believed to be fluent in a language
may have limited fluency in that language, which could hinder the effectiveness of communi-
cation in a patient-provider concordant pair); this is one possible explanation for the lower
rates of return for testing in the intervention arm.
Risk of bias in included studies
All seven studies were at high risk of bias (Fig 3). In the sole RCT (Tanke 1997), methods for
randomizing participants to group and allocation concealment were not described and blind-
ing of participants and outcome assessors was either not done or not described.[27] As no
study protocol was available in the Tanke 1997 study, we were unable to ascertain whether or
not outcomes were reported selectively. Finally, since the authors are financially invested in a
company selling equipment for telephone reminder messages, we considered this study being
at high risk of “potential” bias due to conflict of interest, although this does not necessarily
mean the study’s findings were affected by this bias.[27] Rates of return for test interpretation
were very high in both arms of the RCT; the inclusion of children in the sample may have
introduced a potential source of bias; as parents are often more responsive to their children’s
medical needs than their own. However, the inclusion of children cannot entirely explain the
high rates of return; the original paper reported that the most adherent group was the oldest
age cohort (those over the age of 29 years). Tanke 1994, also included children in the sample
but didn’t find any significant differences in message effectiveness by age group.[28]
The other six studies were non-randomized.[22, 24–26, 28, 31] Among five,[22, 24–26, 31]
none blinded participants, personnel or outcome assessors to the intervention status. This
information was unclear in Tanke 1994.[28] With study protocols unavailable, the risk of out-
come reporting bias in all studies was also unclear. Three studies[22, 26, 28] used clinic records
or administrative data. In two studies,[24, 31] groups were socio-demographically comparable
from baseline to intervention, but comparability of groups was unclear because of lack of
reported data for both phases in the four others.[22, 25, 26, 28]
With regard to risk of measurement bias, it was low in two studies,[22, 25, 26] unclear in
three others,[24, 28, 31] and high in one study.[26] Steele and colleagues assessed outcomes by
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reviewing random samples of patient charts, but they did not describe their sampling methods.
As mentioned in the results section, in Leng 2011, some providers deemed language-concor-
dant may have had “false fluency” in their languages but this was unclear. Referral proportions
in both groups were very low, and investigators speculated that among other possibilities, par-
ticipants may have refused referral. In Tanke 1994, investigators did not report if or how they
verified that messages were actually delivered. The study by Anand et al. was ranked as high
for risk of measurement bias because it is unclear what tools or protocols (if any) were being
used to document patients who were screened for LTBI prior to the intervention.
Four studies (Kemper et al., Anand et al., Tanke 1994, and Leng et al.)[22, 26, 28, 31] were
considered at low risk of bias for follow-up duration. Tanke 1994 and Leng et al.[28, 31] both
targeted patients for short-term behavior change or after behavior modification (such as
attending an appointment for a test or receiving language concordant care at a single visit).
The participants were followed long enough to capture the outcomes of interest and were
therefore viewed as having an adequate follow-up duration. Kempker et al., Anand et al.,
Shultz et al. and Steele et al. all targeted providers and clinic personnel.[22, 24–26] Kempker
et al. followed providers for five months after intervention implementation and Anand et al.
followed them for fourteen months [22, 26]; both of these studies were considered to be at low
risk for follow-up bias because these follow-up durations were considered sufficient (> 3
months) to determine if the intervention had changed provider and clinic personnel behaviors
around screening. Shultz et al. and Steele et al. were both considered to be at high risk because
Fig 3. Systematic review of healthcare facility-based strategies to improve targeted testing for latent tuberculosis
infection in non-U.S.-born populations in the United States. LEGEND: Green = low risk of bias, White = risk of bias
unclear, Red = high risk of bias.
https://doi.org/10.1371/journal.pone.0223077.g003
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the follow-up period was < 3 months, which was considered insufficient to measure true
behavior change retention of provider screening practices.[24, 25] Finally, all six non-random-
ized studies (all included studies except Tanke 1997) were at high risk of bias for not control-
ling for potential confounders. See Fig 3 for a summary assessment of bias risk in each
included study.
Quality of the evidence. The evidence quality for all interventions reviewed here is very
low. Thus, we can have little confidence in the stability or accuracy of any effect estimate. All
studies were at high risk of bias, including the only RCT. We down-graded the evidence qual-
ity in Tanke (1997) to very low (by three levels), for lack of blinding of patients, personnel and
outcome assessors and for high risk of bias due to conflict of interest.[27] We also judged the
other six non-randomized studies as providing low-quality evidence, because they were non-
randomized, none of them reported using statistical methods to adjust for confounders, and
one had imprecision due to the small numbers of participants.[26]
Discussion
Despite systematically reviewing the scientific literature to find studies to improve TB infection
screening of non-U.S.-born populations in healthcare settings in the U.S., we identified only
seven studies, all of poor methodologic quality. Three of these studies [27, 28, 31] targeted
patients to improve targeted TB infection testing and linkage to care while four targeted pro-
viders and clinic personnel.[22, 24–26] Two of the studies targeting patients used telephone
reminders to remind patients to return for their next appointment. Tanke et al. (1997)[27] saw
statistically significant differences in rates of return for TST interpretation but in their earlier
study (1994) Tanke et al. saw no significant difference in rates of chest x-ray appointment
attendance between participants in the intervention arm and those in the control arm.[28] The
four interventions[22, 24–26] targeting providers all had statistically significant improvements
in the intervention arm for at least one of the outcomes of interest reported.
Of the interventions targeting providers, three implemented a multifaceted “quality
improvement” intervention, each comprised of education and training for clinic staff and pro-
viders; the development of LTBI risk screening materials (questionnaires and visibly posted
screening guidelines) for the clinic; and reminders to provide a TB infection test for those who
are deemed “at risk”. Kempker et al.’s intervention saw the largest effect size (RR 24.6 CI 3.5 to
174.1; p = 0.001 for referral for TB infection testing), but given the wide confidence interval,
caution is needed when interpreting these results.[22] Anand et al., who implemented a similar
intervention with an education component to improve provider administered LTBI risk
screening (through a questionnaire and when warranted, TB infection testing), saw a statisti-
cally significant increase in rates of provider risk screening (p<0.001), but a reliable effect size
could not be calculated due to the small sample size in the pre-intervention arm.[26] Similarly,
Schultz et al. saw statistically significant improvements in receipt of IGRA TB infection test
among those identified as being “at risk” of LTBI (p<0.001).[25] The final study aimed at pro-
viders (Leng 2011) used a clinical decision support system to flag patient’s medical files if they
should be tested for TB infection.[31] This study assessed differences in the rate of TB infection
testing referral and testing uptake among those in the intervention and control arm. While
there was a statically significant improvement in rates of referral in the post-intervention arm,
the improvement in TB infection testing rates was not significant.
Although healthcare facilities play an important role in dealing with the LTBI epidemic
among non-U.S.-born persons, there is a paucity of studies that rigorously assessed the effect
of healthcare facility-based interventions to improve outcomes along the LTBI test and treat
cascade among this population in the U.S.. Comparative studies that utilize techniques such as
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randomized allocation of intervention and blinding are needed to produce reliable evidence
for these interventions. While other systematic reviews mentioned below have looked at the
value of targeted TB infection testing and treatment among populations at high risk of LTBI,
to our knowledge this is the only systematic review that required a comparator arm and
focused on the testing portion of the TTT cascade in healthcare facilities in the U.S. Impor-
tantly, LTBI diagnostics and treatment regimens have changed over the time period of this
review and these changes could impact willingness to be tested and referred to treatment. In
2001, QuantiFERON1, an interferon gamma release assay (IGRA) was approved by the FDA
for TB infection testing, eliminating the need to return to have test results read 48–72 hours
after having a TST placed. However, TST remains common and all but one of the studies
included in this review relied on it for testing.
Evidence from other diseases
The strategies used to improve targeted TB testing in reviewed studies are not unique to TB
and have been successfully used to improve screening and testing uptake for other chronic
infections such as hepatitis B virus (HBV) and hepatitis C virus (HCV). For instance, an RCT
among providers in 15 primary care clinics in California found that the study arm that
received “alerts” to screen for HBV when a patient’s surname was of Chinese or Vietnamese
origin (vs no alert) improved proportion of patients who were offered testing (36/88 vs 1/87;
p<0.001) as well as testing completion (30/36 vs 0/1; p<0.001).[32] HepCAT, a comparable
multifaceted intervention to improve targeted HCV testing using “risk-based” sticker alerts in
patient charts, in conjunction with patient, provider and staff knowledge transfer and HCV
awareness posters, saw an improvement of testing among patients with�1 risk factor from 5%
to 14% after 15 weeks of the intervention (n = 7846).[33, 34]
In the absence of sufficient TB infection screening specific literature, high quality systematic
reviews of strategies aiming to improve health outcomes through organizational changes or
enhancing provider practice or behavior may provide insights to design and test interventions
to improve targeted TB infection testing. A Cochrane systematic review[35] of continuing edu-
cation found that it improved provider compliance with desired practice behavior (risk differ-
ence [RD] 6.0, interquartile range [IQR] +2% to +15%). Electronic prompts and reminders in
health records led to a 5% (IQR +3% to +11%) median absolute improvement of care in
another Cochrane review.[36] A Cochrane review[37] of audit and feedback strategies found a
weighted median adjusted RD of 4% (IQR +1% to +16%) in provider compliance with desired
practice.
With regard to improving patient uptake of screening or tests, a few systematic reviews
have examined existing strategies.37 A Cochrane review38 of personalized risk communication
with providers improved patients’ informed decision-making about screening (odds ratio
[OR] 3.65, 95% CI 2.13 to 6.23). Another Cochrane review39 of “decision aids” improved
patient knowledge about screening (mean difference [MD] 13.34/100; 95% CI 11.17 to 15.51).
Limitations of this review
Our findings should be interpreted with caution for several reasons. First, we found few eligi-
ble studies. Despite exhaustive searches and rigorous review methods, we could have missed
unpublished research conducted in non-U.S.-born populations by state or local health depart-
ments. The studies we did find were all at high risk of bias. The generalizability of our findings
may be limited due to small sample sizes, lack of demographic data and the heterogeneity of
study settings.
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Most of the studies we found were pre-post and analyzed administrative data. We believe
that when a change is observed from baseline to after intervention, it is likely real. However,
we are also aware that such administrative evaluations may get published preferentially when
they suggest an effect, since authors are more eager to share what worked and journals are
more willing to publish it. Thus, we think there is a large potential for publication bias. Addi-
tionally, sample sizes for the pre-intervention arm for some of the studies included were very
small, prohibiting our ability to calculate meaningful effect sizes (e.g. Anand).[26] In addition,
we expect that changes observed in pre-post data might not be fully a result of the intervention.
The change may be partially the result of a contemporaneous event (that may have also insti-
gated the intervention, or just happened to coincide), or due to changes in characteristics of
providers or patients. Finally, four of the studies in our review were rather old (data collection
concluded prior to 2010), and all but one included study [25] reporting TB infection testing
outcomes used TST, which limits the applicability of our findings to testing programs that are
increasingly using IGRA.
Authors’ conclusions
While the quality of evidence from the included studies was very low and data were sparse, our
findings suggest that multifaceted strategies combining media, patient and/or provider educa-
tion and staff training on screening for risk of LTBI, as well as those that utilize automated
patient appointment reminders, show promise. All of the studies targeting providers saw sig-
nificant improvements in the intervention arm for at least one reported step in the testing cas-
cade while only one of the studies targeting patients saw significant improvement, suggesting
interventions targeting provider behavior change may have a greater impact. Our certainty
about the stability or accuracy of any effect estimate from the studies included in this review is
very limited. All of the studies captured in this review targeted either patients or providers to
improve screening for LTBI risk factors or TB infection testing among those identified as
being “at risk” of LTBI. Additional high-quality studies are urgently needed to examine this
important public health issue more closely. Future studies should explore combining these two
approaches (patient-centered and provider-centered approaches) for a more robust interven-
tion. Additional rigorous research (in the form of randomized controlled trials) is needed to
ascertain the most effective strategies to improve targeted TB infection testing and reduce the
burden of LTBI in the U.S., and comparative evaluations are needed to substantiate these find-
ings. At minimum, future studies that do not use a randomized study design should ensure
sufficient demographic data is collected for the control/pre-intervention arm to allow for
meaningful comparison of intervention effect across groups.
Public health implications
There is a need for rigorous research including control or comparison populations of innova-
tive strategies to improve TB infection testing in non-U.S.-born populations in healthcare set-
tings. These strategies can contribute to TB elimination efforts.
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